Biotechs propose solutions to impending shortage of AI talent

Competition for AI talent is about to get fierce as companies across biopharma, and every other sector, begin to deploy machine learning in house. Right now, biotechs are aiming to fill their talent needs through academic collaborations and appealing to mission-driven AI specialists, but long-term solutions are needed to meet a demand that could reach as high as tens of thousands of new employees over the next decade.

Biopharma’s biggest competitors for AI talent are tech companies like Google parent Alphabet Inc. (NASDAQ:GOOG) and Facebook Inc. (NASDAQ:FB), which can offer more attractive financial packages to AI post-docs. ...